Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

Chung, Kenny K.K., Zhang, Yi, Lim, Kah Leong, Tanaka, Yuji, Huang, Hui, Gao, Jun, Ross, Christopher A., Dawson, Valina L. +1 more·2001·Nature Medicine
DOI 10.1038/nm1001-1144

Cited by (744)

Items 101–200 of 744

  1. Genome Screen to Identify Susceptibility Genes for Parkinson Disease in a Sample without parkin Mutations
    Nathan Pankratz, William C. Nichols, Sean K. Uniacke, Cheryl A. Halter, Alice Rudolph, Cliff W. Shults, P. Michael Conneally, Tatiana Foroud · 2002 · The American Journal of Human Genetics
  2. Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
    Li, Chunxiao, Cui, Li, Yang, Yimin, Miao, Jing, Zhao, Xiuzhen, Zhang, Jingdian, Cui, Guohong, Zhang, Ying · 2019 · Frontiers in Molecular Neuroscience
  3. Genes, proteins, and neurotoxins involved in Parkinson’s disease
    Oliver von Bohlen und Halbach, Andreas Schober, Kerstin G. KRIEGLSTEIN · 2004 · Progress in Neurobiology
  4. Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant α-Synuclein
    Xiao‐Hong Lu, Sheila M. Fleming, Bernhard H. Meurers, Larry C. Ackerson, Farzad Mortazavi, Victor Lo, Daniela Hernandez, David Sulzer, George R. Jackson, Nigel T. Maidment et al. · 2009 · Journal of Neuroscience
  5. Mitophagy and age-related pathologies: Development of new therapeutics by targeting mitochondrial turnover
    Konstantinos Palikaras, Ioanna Daskalaki, Maria Markaki, Nektarios Tavernarakis · 2017 · Pharmacology & Therapeutics
  6. Monoubiquitylation of α-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells
    Ruth Rott, Raymonde Szargel, Joseph Haskin, Vered Shani, Alla Shainskaya, Irena Manov, Esti Liani, Eyal Avraham, Simone Engelender · 2007 · Journal of Biological Chemistry
  7. Effect of Wild-type or Mutant Parkin on Oxidative Damage, Nitric Oxide, Antioxidant Defenses, and the Proteasome
    Hyun, Dong-Hoon, Lee, MoonHee, Hattori, Nobutaka, Kubo, Shin-Ichiro, Mizuno, Yoshikuni, Halliwell, Barry, Jenner, Peter · 2002 · Journal of Biological Chemistry
  8. Genetic mouse models of parkinsonism: Strengths and limitations
    Sheila M. Fleming, Pierre‐Olivier Fernagut, Marie‐Françoise Chesselet · 2005 · NeuroRx
  9. Ubiquitination of -synuclein by Siah-1 promotes -synuclein aggregation and apoptotic cell death
    J. T. Lee, Tiffany C. Wheeler, Lian Li, Lih‐Shen Chin · 2007 · Human Molecular Genetics
  10. The PINK1, synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway
    Raymonde Szargel, Vered Shani, Fatimah Abd Elghani, Lucy N. Mekies, Esti Liani, Ruth Rott, Simone Engelender · 2016 · Human Molecular Genetics
  11. The ubiquitin system: pathogenesis of human diseases and drug targeting
    Aaron J. Ciechanover, Alan L. Schwartz · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  12. Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy
    Dong Chen, Feng Gao, Bin Li, Hongfeng Wang, Yuxia Xu, Cuiqing Zhu, Guanghui Wang · 2010 · Journal of Biological Chemistry
  13. Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation
    Fanjun Meng, Dongdong Yao, Yang Shi, Jonathan Kabakoff, Wei Wu, Joshua Jay Reicher, Yuliang Ma, Bernd Moosmann, Eliezer Masliah, Stuart A. Lipton et al. · 2011 · Molecular Neurodegeneration
  14. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease
    Kevin St. P. McNaught, C. Warren Olanow · 2005 · Neurobiology of Aging
  15. Update on Parkinson Disease
    Andrew D. Siderowf, Matthew Stern · 2003 · Annals of Internal Medicine
  16. Pathogenetic mechanisms of parkin in Parkinson's disease
    Nobutaka Hattori, Yoshikuni Mizuno · 2004 · The Lancet
  17. RING finger 1 mutations in Parkin produce altered localization of the protein
    Mark Cookson · 2003 · Human Molecular Genetics
  18. Autophagy-mediated clearance of aggresomes is not a universal phenomenon
    Esther S.P. Wong, Jeanne M.M. Tan, Wen-E Soong, Kamila Hussein, Nobuyuki Nukina, Valina Lynn Dawson, Ted M. Dawson, Ana María Cuervo, Kah‐Leong Lim · 2008 · Human Molecular Genetics
  19. Proteasome system of protein degradation and processing
    Alexey V. Sorokin, E. R. Kim, Lev P. Ovchinnikov · 2009 · Biochemistry (Moscow)
  20. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease
    Ari Barzilai, Eldad Melamed · 2003 · Trends in Molecular Medicine
  21. Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutations
    Katja Hedrich, Karen S. Marder, Juliette M. Harris, M. Kann, Timothy Lynch, Helen Meija‐Santana, Peter Paul Pramstaller, EBERHARD SCHWINGER, Susan Bressman, Stanley Fahn et al. · 2002 · Neurology
  22. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system
    Femke M. S. de Vrij, David F. Fischer, F VANLEEUWEN, Elly M. Hol · 2004 · Progress in Neurobiology
  23. Association of the Cytoskeletal GTP-binding Protein Sept4/H5 with Cytoplasmic Inclusions Found in Parkinson's Disease and Other Synucleinopathies
    Masafumi Ihara, Hidekazu Tomimoto, Hitoshi Kitayama, Yoko Morioka, Ichiro Akiguchi, H. Shibasaki, Makoto Noda, Makoto Kinoshita · 2003 · Journal of Biological Chemistry
  24. Redox Reactions Induced by Nitrosative Stress Mediate Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases
    Zezong Gu, Tomohiro Nakamura, Stuart A. Lipton · 2010 · Molecular Neurobiology
  25. Novel Monoclonal Antibodies Demonstrate Biochemical Variation of Brain Parkin with Age
    Aaron C. Pawlyk, Benoit I. Giasson, Deepak M. Sampathu, Francisco A. Perez, Kah Leong Lim, Valina Lynn Dawson, Ted M. Dawson, Richard D. Palmiter, John Q. Trojanowski, Virginia M.‐Y. Lee · 2003 · Journal of Biological Chemistry
  26. A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine
    Tzu‐Kang Sang, Hui-Yun Chang, George M. Lawless, Anuradha Ratnaparkhi, Lisa Mee, Larry C. Ackerson, Nigel T. Maidment, David E. Krantz, George R. Jackson · 2007 · Journal of Neuroscience
  27. Pael‐R is accumulated in Lewy bodies of Parkinson's disease
    Tetsuro Murakami, Mikio Shoji, Yuzuru Imai, Haruhisa Inoue, Takeshi Kawarabayashi, Etsuro Matsubara, Yasuo Harigaya, Atsushi Sasaki, Ryōsuke Takahashi, Koji Abe · 2004 · Annals of Neurology
  28. Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
    Su, Xiaomin, Federoff, Howard J., Maguire-Zeiss, Kathleen A. · 2009 · Neurotoxicity Research
  29. Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder
    Asmat Ullah Khan, Muhammad Akram, Muhammad Daniyal, Rida Zainab · 2018 · International Journal of Neuroscience
  30. What causes cell death in Parkinson's disease?
    Amitabh Gupta, Valina Lynn Dawson, Ted M. Dawson · 2009 · Annals of Neurology
  31. Parkin-mediated lysine 63-linked polyubiquitination: A link to protein inclusions formation in Parkinson's and other conformational diseases?
    Kah‐Leong Lim, Valina Lynn Dawson, Ted M. Dawson · 2005 · Neurobiology of Aging
  32. The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes
    Maria G. Macedo · 2003 · Human Molecular Genetics
  33. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease
    F. P. Marx · 2003 · Human Molecular Genetics
  34. Parkin Accumulation in Aggresomes Due to Proteasome Impairment
    Eunsung Junn, Sang Seop Lee, Unsun T. Suhr, M. Maral Mouradian · 2002 · Journal of Biological Chemistry
  35. Inactivation of Parkin by Oxidative Stress and C-terminal Truncations
    Konstanze F. Winklhofer, Iris H. Henn, Penelope C. Kay-Jackson, Ulrich Heller, Jörg Tatzelt · 2003 · Journal of Biological Chemistry
  36. Toxicity of different zinc oxide nanomaterials and dose-dependent onset and development of Parkinson’s disease-like symptoms induced by zinc oxide nanorods
    Meng Jin, Ning Li, Wenlong Sheng, Xiuna Ji, Xiu Hong Liang, Biao Kong, Penggang Yin, Yong Li, Xingshuang Zhang, Kechun Liu · 2020 · Environment International
  37. Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson?s disease
    Vincenzo Bonifati, Ben A. Oostra, Peter Heutink · 2004 · Journal of Molecular Medicine
  38. Ubiquitination of α-Synuclein Is Not Required for Formation of Pathological Inclusions in α-Synucleinopathies
    Deepak M. Sampathu, Benoit I. Giasson, Aaron C. Pawlyk, John Q. Trojanowski, Virginia M.‐Y. Lee · 2003 · American Journal Of Pathology
  39. M itochondrial DNA and primary mitochondrial dysfunction in P arkinson's disease
    Maria Pia Giannoccaro, Chiara La Morgia, Giovanni Rizzo, Valério Carelli · 2017 · Movement Disorders
  40. Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration
    Katrin Beyer, Aurelio Ariza · 2012 · Molecular Neurobiology
  41. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
    Tito Calí, Denis Ottolini, Marisa Brini · 2011 · BioFactors
  42. Parkin Stabilizes Microtubules through Strong Binding Mediated by Three Independent Domains
    Fang Yang, Qian Jiang, Jinghui Zhao, Yong Ren, Mark D. Sutton, Jian Feng · 2005 · Journal of Biological Chemistry
  43. Genetics of Parkinson's disease
    Thomas Gasser · 2004 · Dialogues in Clinical Neuroscience
  44. Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms
    Gianluigi Forloni, Liana Terreni, Ilaria Bertani, Sergio Fogliarino, Roberto William Invernizzi, Andrea Assini, Giuseppe Ribizzi, Alessandro Negro, Elena Calabrese, Maria Antonietta Volonté · 2002 · Neurobiology of Aging
  45. Parkin-mediated Monoubiquitination of the PDZ Protein PICK1 Regulates the Activity of Acid-sensing Ion Channels
    Monica Joch, Ariel R. Ase, Carol X.‐Q. Chen, Penny A. MacDonald, Maria Kontogiannea, Amadou Tidjane Corera, Alexis Brice, Philippe Séguéla, Edward A. Fon · 2007 · Molecular Biology of the Cell
  46. How does parkin ligate ubiquitin to Parkinson's disease?
    Philipp J. Kahle, Christian Haass · 2004 · EMBO Reports
  47. Dysfunction of the ubiquitin–proteasome system in multiple disease conditions: therapeutic approaches
    Subhankar Paul · 2008 · BioEssays
  48. Parkin-associated Parkinson’s disease
    Rainer von Coelln, Valina Lynn Dawson, Ted M. Dawson · 2004 · Cell and Tissue Research
  49. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system
    Leonardo Petrucelli, Ted M. Dawson · 2004 · Annals of Medicine
  50. α-Synuclein and Neuronal Cell Death
    Toru Yasuda, Yasuto Nakata, Hideki Mochizuki · 2012 · Molecular Neurobiology
  51. Parkinson's disease: convergence on synaptic homeostasis
    Sandra‐Fausia Soukup, Roeland Vanhauwaert, Patrik Verstreken · 2018 · The EMBO Journal
  52. parkin counteracts symptoms in a Drosophila model of Parkinson's disease
    Annika F.M. Haywood, Brian E. Staveley · 2004 · BMC Neuroscience
  53. α-Synuclein and Parkin Contribute to the Assembly of Ubiquitin Lysine 63-linked Multiubiquitin Chains
    Ellen Doss-Pepe, Li Chen, Kiran Madura · 2005 · Journal of Biological Chemistry
  54. Proteasomal Inhibition-Induced Inclusion Formation and Death in Cortical Neurons Require Transcription and Ubiquitination
    Hardy J. Rideout, Leonidas Stefanis · 2002 · Molecular and Cellular Neuroscience
  55. Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
    Atossa Shaltouki, Renuka Sivapatham, Ying Pei, Akos A. Gerencser, Olga Momčilović, Mahendra S. Rao, Xianmin Zeng · 2015 · Stem Cell Reports
  56. The Small Heat-shock Protein αB-Crystallin Promotes FBX4-dependent Ubiquitination
    John den Engelsman, Vivian Keijsers, Wilfried W. DE JONG, Wilbert C. Boelens · 2003 · Journal of Biological Chemistry
  57. Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells
    Francesco Fornai, Paola Lenzi, Marco Gesi, Paola Soldani, Michela Ferrucci, Gloria Lazzeri, Loredana Capobianco, Giuseppe Battaglia, Antonio De Blasi, Ferdinando Nicoletti et al. · 2003 · Journal of Neurochemistry
  58. 14‐3‐3η is a novel regulator of parkin ubiquitin ligase
    Shigeto Sato, Tomoki Chiba, Eri Sakata, Koichi Kato, Yoshikuni Mizuno, Nobutaka Hattori, Keiji Tanaka · 2005 · The EMBO Journal
  59. Genetics of Parkinson disease
    Nathan Pankratz, Tatiana Foroud · 2007 · Genetics in Medicine
  60. Leucine‐rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
    Payal N. Gandhi, Shu G. Chen, Amy L. Wilson‐Delfosse · 2008 · Journal of Neuroscience Research
  61. SEPT5_v2 is a parkin-binding protein
    P. Choi, Heather M. Snyder, Leonard Petrucelli, Catherine M. Theisler, M. Chong, Yuesheng Zhang, Kah‐Leong Lim, Kenny K. K. Chung, Kathryn J. Kehoe, Luciano D'adamio et al. · 2003 · Molecular Brain Research
  62. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1
    Zhizhong Dong, Boris Ferger, Jean‐Charles Paterna, Denise Vogel, Sven Furler, Maribel Osinde, Joram Feldon, Hansruedi Büeler · 2003 · Proceedings of the National Academy of Sciences
  63. Phosphorylated tau and the neurodegenerative foldopathies
    Kenneth S. Kosik, Hideki Shimura · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  64. Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease‐linked point mutations
    Cheng Wang, Jeanne M.M. Tan, Michelle W. L. Ho, Norazean Zaiden, Siew Heng Wong, Constance L. C. Chew, Pei Woon Eng, Tit Meng Lim, Ted M. Dawson, Kah Leong Lim · 2005 · Journal of Neurochemistry
  65. Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation
    Eyal Avraham, Ruth Rott, Esti Liani, Raymonde Szargel, Simone Engelender · 2007 · Journal of Biological Chemistry
  66. Staring, a Novel E3 Ubiquitin-Protein Ligase That Targets Syntaxin 1 for Degradation
    Lih‐Shen Chin, John Paul Vavalle, Lian Li · 2002 · Journal of Biological Chemistry
  67. The contributions of rare inherited and polygenic risk to ASD in multiplex families
    Matilde Cirnigliaro, Timothy S. Chang, Stephanie A. Arteaga, Laura Pérez‐Cano, Elizabeth K. Ruzzo, Aaron Gordon, Lucy K. Bicks, Jae-Yoon Jung, Jennifer K. Lowe, Dennis Paul Wall et al. · 2023 · Proceedings of the National Academy of Sciences
  68. Molecular Pathology of Lewy Body Diseases
    Katrin Beyer, Montserrat Domingo-Sàbat, Aurelio Ariza · 2009 · International Journal of Molecular Sciences
  69. Synphilin-1 Is Developmentally Localized to Synaptic Terminals, and Its Association with Synaptic Vesicles Is Modulated by α-Synuclein
    Cátia S. Ribeiro, K. Carneiro, Christopher A. Ross, João R.L. Menezes, Simone Engelender · 2002 · Journal of Biological Chemistry
  70. Protein Misfolding and Aggregation in Parkinson's Disease
    Jeanne M.M. Tan, Esther S.P. Wong, Kah‐Leong Lim · 2009 · Antioxidants and Redox Signaling
  71. Parkin: a multifaceted ubiquitin ligase
    Darren J. Moore · 2006 · Biochemical Society Transactions
  72. Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity
    Ayako Yamamoto, Arno Friedlein, Yuzuru Imai, Ryōsuke Takahashi, Philipp J. Kahle, Christian Haass · 2004 · Journal of Biological Chemistry
  73. Ubiquitin, proteasome and parkin
    Keiji Tanaka, Toshiaki Suzuki, Nobutaka Hattori, Yoshikuni Mizuno · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  74. Inhibition of Proteasomal Activity Causes Inclusion Formation in Neuronal and Non-Neuronal Cells Overexpressing Parkin
    H.C. Ardley, Gina B. Scott, Stephen A. Rose, Nancy G. S. Tan, Alexander F. Markham, Philip Alan Robinson · 2003 · Molecular Biology of the Cell
  75. Parkin and relatives: the RBR family of ubiquitin ligases
    Ignacio Marı́n, José Ignacio Lucas‐Lledó, Ana‐Citlali Gradilla, Alberto Ferrús · 2004 · Physiological Genomics
  76. Casein Kinase II-mediated Phosphorylation Regulates α-Synuclein/Synphilin-1 Interaction and Inclusion Body Formation
    Gwang Lee, Mikiei Tanaka, Kiho Park, Sang Seop Lee, Yong Man Kim, Eunsung Junn, Sang‐Hyeon Lee, M. Maral Mouradian · 2004 · Journal of Biological Chemistry
  77. Parkin
    Mel Β. Feany, Leo J. Pallanck · 2003 · Neuron
  78. Synapses in neurodegenerative diseases
    Jae Ryul Bae, Sung Hyun Kim · 2017 · BMB Reports
  79. Parkin-positive autosomal recessive juvenile parkinsonism with α-synuclein-positive inclusions
    Shoichi Sasaki, Akiko Shirata, Kiyomi Yamane, Makoto Iwata · 2004 · Neurology
  80. A Caenorhabditis elegans Parkin mutant with altered solubility couples α-synuclein aggregation to proteotoxic stress
    Wolfdieter Springer, Thorsten Hoppe, Enrico Schmidt, Ralf Baumeister · 2005 · Human Molecular Genetics
  81. Siah-1 Facilitates Ubiquitination and Degradation of Synphilin-1
    Yoshito Nagano, Hiroshi Yamashita, Tetsuya Takahashi, Shosei Kishida, Takeshi Nakamura, Eizo Iseki, Nobutaka Hattori, Yoshikuni Mizuno, Akira Kikuchi, Masayasu Matsumoto · 2003 · Journal of Biological Chemistry
  82. Genes and parkinsonism
    John Hardy, Mark Cookson, Andrew Singleton · 2003 · The Lancet Neurology
  83. A first order phase transition mechanism underlies protein aggregation in mammalian cells
    Arjun Narayanan, Anatoli B. Meriin, J Owen Andrews, Jan-Hendrik Spille, Michael Y. Sherman, Ibrahim I. Cissé · 2019 · eLife
  84. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
    Kathleen A. Maguire‐Zeiss, Douglas W. Short, Howard J. Federoff · 2004 · Molecular Brain Research
  85. Mouse and fly models of neurodegeneration
    Huda Yahya Zoghbi, Juan Botas · 2002 · Trends in Genetics
  86. Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer’s and Parkinson’s diseases
    Elena V. Stelmashook, Н. К. Исаев, Е. Е. Генрихс, G. A. Amelkina, Л. Г. Хаспеков, Vladimir G. Skrebitsky, Sergey Nikolaevich Illarioshkin · 2014 · Biochemistry (Moscow)
  87. A LON-ClpP Proteolytic Axis Degrades Complex I to Extinguish ROS Production in Depolarized Mitochondria
    Kenneth R. Pryde, Jan‐Willem Taanman, Anthony H.V. Schapira · 2016 · Cell Reports
  88. Impact of recent genetic findings in Parkinson??s disease
    Christine Klein, Katja Lohmann-Hedrich · 2007 · Current Opinion in Neurology
  89. Chaperones and aging: role in neurodegeneration and in other civilizational diseases
    Csaba Sőti, Péter Csermely · 2002 · Neurochemistry International
  90. Parkin Gene Therapy for α-Synucleinopathy: A Rat Model of Parkinson's Disease
    Masanori Yamada, Yoshikuni Mizuno, Hideki Mochizuki · 2005 · Human Gene Therapy
  91. Cross‐linking of ubiquitin, HSP27, parkin and α‐synuclein by γ‐glutamyl‐ε‐lysine bonds in Alzheimer's neurofibrillary tangles
    Zoltán Nemes, Bart V. Devreese, Peter M. Steinert, Jozef VAN BEEUMEN, László Fésüs · 2004 · The FASEB Journal
  92. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer’s and Parkinson’s diseases
    Tomohiro Nakamura, Stuart A. Lipton · 2010 · APOPTOSIS
  93. Emerging Roles of S -Nitrosylation in Protein Misfolding and Neurodegenerative Diseases
    Tomohiro Nakamura, Stuart A. Lipton · 2007 · Antioxidants and Redox Signaling
  94. Parkinsonism genes: culprits and clues
    Asa Abeliovich, M. Flint Beal · 2006 · Journal of Neurochemistry
  95. Polyunsaturated Fatty Acids Induce α-Synuclein-Related Pathogenic Changes in Neuronal Cells
    Karen Assayag, Evgenia Yakunin, Virginie Loeb, Dennis J. Selkoe, Ronit Sharon · 2007 · American Journal Of Pathology
  96. Protein aggregation as a paradigm of aging
    Ariel B. Lindner, Alice Démarez · 2009 · Biochimica et Biophysica Acta (BBA) - General Subjects
  97. How to get rid of mitochondria: crosstalk and regulation of multiple mitophagy pathways
    Marcel Zimmermann, Andreas S. Reichert · 2017 · Biological Chemistry
  98. Functional modulation of parkin through physical interaction with SUMO‐1
    Ji Won Um, Kwang Chul Chung · 2006 · Journal of Neuroscience Research
  99. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease
    Steven Beasley, Ventzislava A. Hristova, Gary S. Shaw · 2007 · Proceedings of the National Academy of Sciences
  100. Parkin mediates the degradation‐independent ubiquitination of Hsp70
    Darren J. Moore, Andrew B. West, Dustin A. Dikeman, Valina Lynn Dawson, Ted M. Dawson · 2008 · Journal of Neurochemistry